» Articles » PMID: 20109730

An Update on the Genetics of Atopic Dermatitis: Scratching the Surface in 2009

Overview
Date 2010 Jan 30
PMID 20109730
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

A genetic basis for atopic dermatitis (AD) has long been recognized. Historic documents allude to family history of disease as a risk factor. Before characterization of the human genome, heritability studies combined with family-based linkage studies supported the definition of AD as a complex trait in that interactions between genes and environmental factors and the interplay between multiple genes contribute to disease manifestation. A summary of more than 100 published reports on genetic association studies through mid-2009 implicates 81 genes, in 46 of which at least 1 positive association with AD has been demonstrated. Of these, the gene encoding filaggrin (FLG) has been most consistently replicated. Most candidate gene studies to date have focused on adaptive and innate immune response genes, but there is increasing interest in skin barrier dysfunction genes. This review examines the methods that have been used to identify susceptibility genes for AD and how the underlying pathology of this disease has been used to select candidate genes. Current challenges and the potential effect of new technologies are discussed.

Citing Articles

Increased intracellular stress responses and decreased KLF2 in adult patients with atopic dermatitis.

Sugiura S, Sugiura S, Yoshida H, Yoshida H, Sugiura H, Sugiura H Cell Stress Chaperones. 2025; 30(2):84-99.

PMID: 39938773 PMC: 11891603. DOI: 10.1016/j.cstres.2025.02.001.


Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights.

Abdel-Mageed H Inflammopharmacology. 2025; .

PMID: 39918744 DOI: 10.1007/s10787-025-01642-z.


Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis.

Chou S, Chuang Y, Chen B Int J Mol Sci. 2024; 25(19).

PMID: 39409019 PMC: 11477013. DOI: 10.3390/ijms251910691.


Examining the association between autism spectrum disorder and atopic eczema: meta-analysis of current evidence.

Elgenidy A, Gad E, Shabaan I, Abdelrhem H, Wassef P, Elmozugi T Pediatr Res. 2024; .

PMID: 39128926 DOI: 10.1038/s41390-024-03456-1.


IL-4 acts on skin-derived dendritic cells to promote the T2 response to cutaneous sensitization and the development of allergic skin inflammation.

Leyva-Castillo J, Das M, Strakosha M, McGurk A, Artru E, Kam C J Allergy Clin Immunol. 2024; 154(6):1462-1471.e3.

PMID: 38996877 PMC: 11625010. DOI: 10.1016/j.jaci.2024.06.021.


References
1.
Leung D, Bieber T . Atopic dermatitis. Lancet. 2003; 361(9352):151-60. DOI: 10.1016/S0140-6736(03)12193-9. View

2.
Cork M, Robinson D, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A . New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006; 118(1):3-21. DOI: 10.1016/j.jaci.2006.04.042. View

3.
Colhoun H, McKeigue P, Davey Smith G . Problems of reporting genetic associations with complex outcomes. Lancet. 2003; 361(9360):865-72. DOI: 10.1016/s0140-6736(03)12715-8. View

4.
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L . An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003; 4(7):702-7. DOI: 10.1038/ni945. View

5.
Gazouli M, Koundourakis A, Ikonomopoulos J, Gialafos E, Rapti A, Gorgoulis V . CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006; 23(1):23-9. View